| Literature DB >> 28447859 |
Kendra A Hyland1, Elena L Aronovich2, Erik R Olson1, Jason B Bell2, Myra Urness Rusten3, Roland Gunther4, David W Hunter3, Perry B Hackett2, R Scott McIvor1,2.
Abstract
The Sleeping Beauty transposon system has been extensively tested for integration of reporter and therapeutic genes in vitro and in vivo in mice. Dogs were used as a large animal model for human therapy and minimally invasive infusion of DNA solutions. DNA solutions were delivered into the entire liver or the left side of the liver using balloon catheters for temporary occlusion of venous outflow. A peak intravascular pressure between 80 and 140 mmHg supported sufficient DNA delivery in dog liver for detection of secretable reporter proteins. Secretable reporters allowed monitoring of the time course of gene products detectable in the circulation postinfusion. Canine secreted alkaline phosphatase reporter protein levels were measured in plasma, with expression detectable for up to 6 weeks, while expression of canine erythropoietin was detectable for 7-10 days. All animals exhibited a transient increase in blood transaminases that normalized within 10 days; otherwise the treated animals were clinically normal. These results demonstrate the utility of a secreted reporter protein for real-time monitoring of gene expression in the liver in a large animal model but highlight the need for improved delivery in target tissues to support integration and long-term expression of Sleeping Beauty transposons.Entities:
Keywords: Sleeping Beauty; canine; hydrodynamic; liver; non-viral; transposon
Mesh:
Substances:
Year: 2017 PMID: 28447859 PMCID: PMC5549801 DOI: 10.1089/hum.2017.003
Source DB: PubMed Journal: Hum Gene Ther ISSN: 1043-0342 Impact factor: 5.695